OB/GYN 1006 - OB/GYN Clinical Alert - Jun 01, 2006

Target Audience:

This activity is intended for the obstetrician and gynecologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Editor
Leon Speroff, MD
Professor of Obstetrics and Gynecology
Oregon Health and Science University
Portland

Peer Reviewer
Catherine Leclair, MD
Assistant Professor
Department of OB/GYN
Oregon Health and Science University
Portland

Associate Editors
Sarah L. Berga, MD
James Robert McCord Professor and Chair
Department of Gynecology and Obstetrics
Emory University School of Medicine
Atlanta

John C. Hobbins, MD
Professor and Chief of Obstetrics
University of Colorado Health Sciences Center
Denver

Robert L. Colemen, MD
Associate Professor
University of Texas; M.D.
Anderson Cancer Center
Houston

Subjects:

  • Results of Raloxifene RUTH and STAR Trials
  • Calorie Restriction on Biomarkers of Longevity, Metabolic Adaptation, and Oxidative Stress in Overweight Individuals
  • Membrane Sweeping at Initiation of Labor Induction
  • Angiogenesis and the Strategic Target for Ovarian Cancer Therapy

Objectives:

  • to present the latest data regarding diagnosis and treatment of various diseases affecting women, including cancer, sexually transmitted diseases, and osteoporosis
  • present new data concerning prenatal care and complications, as well as neonatal health
  • discuss the pros, cons, and cost-effectiveness of new testing procedures

Financial Disclosure:

OB/GYN Clinical Alert’s Editor, Leon Speroff, MD, is a consultant for Barr Laboratories.

Peer ReviewerCatherine Leclair, MD reports no financial relationship to this field of study.

Associate Editor Sarah L. Berga, MD is a consultant for Pfizer, Organon, and is involved in research for Berlex and Health Decisions, Inc.

Associate Editor John C. Hobbins, MD reports no financial relationship to this field of study.

Associate Editor Robert L. Coleman, MD is on the speaker’s bureau for GlaxoSmithKline, Bristol-Myers Squibb, and Ortho Biotech.

Copyright 2006 AHC Media. All rights reserved.